[Upcoming Webinar] ESSENCE: Sarepta’s Exon 45 and 53 Skipping Study

Event Details

[Upcoming Webinar] ESSENCE: Sarepta’s Exon 45 and 53 Skipping Study

Time: June 7, 2017 from 1pm to 2pm
Location: Online Webinar - Eastern Time Zone
Website or Map: https://www.readytalk.com/join
Phone: 1.866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: Jun 7, 2017

Export to Outlook or iCal (.ics)

Event Description

Wednesday, June 7 at 1:00 PM EDT

Please join Parent Project Muscular Dystrophy and Sarepta Therapeutics as we host a webinar Wednesday, June 7 at 1:00 PM EDT for an overview of Sarepta’s pivotal study investigating SRP-4045 and SRP-4053 for the treatment of Duchenne muscular dystrophy.


  • Ryan Fischer, SVP Community Engagement, Parent Project Muscular Dystrophy


  • Genevieve Laforet, MD, PhD, ESSENCE Study Medical Director
    Genevieve Laforet, MD, PhD, is a medical director at Sarepta Therapeutics leading the SRP-4053 and SRP-4045 clinical development programs. A psychiatrist and biochemist by training, Dr. Laforet has worked in a variety of therapeutic areas at both bench and bedside, with a focus on neurodegenerative, neurodevelopmental, and neuromuscular diseases.

To Participate:

  1. Visit ReadyTalk.com and use access code 9449985. (Be sure to test your computer beforehand)
  2. Audio Dial-In Information:
    • U.S. & Canada: Dial 1.866.740.1260 and use the Access Code 9449985
    • Outside the U.S. and Canada: Lookup your number

Submit Questions:

Please submit questions in advance to info@parentprojectmd.org, with “ESSENCE Webinar” in the subject line by Monday, June 5th at 12pm eastern.

Comment Wall


RSVP for [Upcoming Webinar] ESSENCE: Sarepta’s Exon 45 and 53 Skipping Study to add comments!

Join PPMD Community

Attending (5)

Might attend (1)

Need help using this community site? Visit Ning's Help Page.



© 2022   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service